comparemela.com

Latest Breaking News On - Professor matthew snape - Page 4 : comparemela.com

Oxford study says mixing COVID-19 vaccines gives good protection

Oxford study says mixing COVID-19 vaccines gives good protection ANI | Updated: Jun 29, 2021 08:18 IST London [UK], June 29 (ANI): Amid the global shortage of the COVID-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. According to the study, mixed schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart. This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against COVID-19.

Oxford study says mixing Covid-19 vaccines gives robust protection

Amid the global shortage of the Covid-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. According to the study, mixed schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart. This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against Covid-19. The Com-COV study has evaluated mix and match combinations of the Oxford and Pfizer vaccines to see to what extent these vaccines can be used interchangeably, potentially allowing flexibility in the UK and global vaccine roll-out, said Professor Matthew Snape, Associate Professor in Paediatrics and Vaccinology at the University of Oxford, and Chief Investigator

Mixing doses of AstraZeneca, Pfizer-BioNTech vaccines gives good protection against COVID-19: Oxford study

Mixing doses of AstraZeneca, Pfizer-BioNTech vaccines gives good protection against COVID-19, says study Alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus, a study conducted by Oxford University has suggested. According to the study, mixed schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart. This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against COVID-19. The Com-COV study has evaluated mix and match combinations of the Oxford and Pfizer vaccines to see to what extent these vaccines can be used interchangeably, potentially allowing flexibility in the UK and global vaccine roll-out, said Professor Matthew Snape, Associate Professor in Paediatrics and Vaccinology at the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.